155 related articles for article (PubMed ID: 16691010)
1. Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.
Moody TW; Nakagawa T; Kang Y; Jakowlew S; Chan D; Jensen RT
J Mol Neurosci; 2006; 28(3):231-8. PubMed ID: 16691010
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
Moody TW; Leyton J; Garcia-Marin L; Jensen RT
Eur J Pharmacol; 2003 Aug; 474(1):21-9. PubMed ID: 12909192
[TBL] [Abstract][Full Text] [Related]
3. ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.
Moody TW; Mantey SA; Moreno P; Nakamura T; Lacivita E; Leopoldo M; Jensen RT
Peptides; 2015 Feb; 64():55-61. PubMed ID: 25554218
[TBL] [Abstract][Full Text] [Related]
4. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
[TBL] [Abstract][Full Text] [Related]
6. Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
Jaeger M; Ghisleni EC; Fratini L; Brunetto AL; Gregianin LJ; Brunetto AT; Schwartsmann G; de Farias CB; Roesler R
Childs Nerv Syst; 2016 Jan; 32(1):61-4. PubMed ID: 26590027
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor.
Langer DA; Kautzman D; Kane MA
Lung Cancer; 2002 Jun; 36(3):235-42. PubMed ID: 12009231
[TBL] [Abstract][Full Text] [Related]
8. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
[TBL] [Abstract][Full Text] [Related]
9. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
[TBL] [Abstract][Full Text] [Related]
10. Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines.
Yang HK; Scott FM; Trepel JB; Battey JF; Johnson BE; Kelley MJ
Lung Cancer; 1998 Sep; 21(3):165-75. PubMed ID: 9857994
[TBL] [Abstract][Full Text] [Related]
11. Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
Zhang Q; Bhola NE; Lui VW; Siwak DR; Thomas SM; Gubish CT; Siegfried JM; Mills GB; Shin D; Grandis JR
Mol Cancer Ther; 2007 Apr; 6(4):1414-24. PubMed ID: 17431120
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
[TBL] [Abstract][Full Text] [Related]
13. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
Hohla F; Schally AV; Kanashiro CA; Buchholz S; Baker B; Kannadka C; Moder A; Aigner E; Datz C; Halmos G
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18671-6. PubMed ID: 18003891
[TBL] [Abstract][Full Text] [Related]
15. The metabolism of BW2258U89, a GRP receptor antagonist.
Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
[TBL] [Abstract][Full Text] [Related]
16. Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells.
Leyton J; Garcia-Marin LJ; Tapia JA; Jensen RT; Moody TW
Cancer Lett; 2001 Jan; 162(1):87-95. PubMed ID: 11121866
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells.
Moody TW; Jensen RT; Garcia L; Leyton J
Eur J Pharmacol; 2000 Dec; 409(2):133-42. PubMed ID: 11104826
[TBL] [Abstract][Full Text] [Related]
18. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
19. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
20. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
